newdrugapprovals.org
FDA approves first PI3K inhibitor Piqray (alpelisib) for breast cancer
FDA approves first PI3K inhibitor for breast cancer syn Today, the U.S. Food and Drug Administration approved Piqray (alpelisib) tablets, to be used in combination with the FDA-approved endocrine …